All news from Ophthalmology

Autofocal Lenses

Autofocal Lenses Might One Day Effectively Correct Vision

Though it may not have the sting of death and taxes, presbyopia is another of life’s guarantees. This vision defect plagues most of us starting about age 45, as the lenses in our eyes lose the elasticity needed to focus on nearby objects. For some people reading glasses suffice to overcome the difficulty; but for…

Retinal Scanner

Low-Cost Retinal Scanner Could Help Prevent Blindness Worldwide

Biomedical engineers at Duke University have develop a low-cost; portable optical coherence tomography (OCT) scanner  or retinal scanner that promises; to bring the vision-saving technology to underserve regions throughout the United States and abroad.  In its first clinical trial, the new OCT scanner produced images of 120 retinas that were 95 %; as sharp as…

Cataracts

Treatment Options For Children With Cataracts

“In children the neural pathways in the brain that carry vision are rapidly developing,” said David Morrison, MD, a pediatric ophthalmologist at Vanderbilt University Medical Center. If cataracts are not remove before babies are 3 months old, “they’ll be permanently blind even if you (operate) afterward due to damage of these neural pathways,” he said.…

Glaucoma

Long-Term Statin Use Associated With Lower Glaucoma Risk

A new study brings the connection between statin use and risk of glaucoma into sharper focus. Investigators from Brigham and Women’s Hospital have found that using statins for five or more years is associate; with lower risk of primary open-angle glaucoma. Results of the study were publish recently in JAMA Ophthalmology. Glaucoma, a leading cause…

Eye microbiome

Microbiome In Eye: Helps To Treat Common Eye Disease

You are familiar with the idea that your gut and skin are home to a collection of microbes like fungi; bacteria and viruses which are vital for keeping you healthy. But did you know that your eyes also host a unique menagerie of microbes? And they are call the eye microbiome. When these microbes are…

Rhodopsin

Study Sheds Light On Rhodopsin Dynamics In Retina

Photoreceptor cells in our eyes can adjust to both weak and strong light levels; but we still don’t know exactly how they do it. Emeritus Professor Fumio Hayashi of Kobe University and his colleagues revealed that the photoreceptor protein rhodopsin; forms transient clusters within the disc membranes in retina. These clusters are concentrate in the…

Eye injury

Tips For Staying Safe From Eye Injury Around Fireworks

An annual report from the U.S. Consumer Product Safety Commission shows that fireworks-relate eye injuries have nearly increase by 2 times; from 700 in 2016 to 1,200 in 2017. Overall, fireworks cause nearly 13,000 injuries in 2017; up from 11,000 in 2016. What is reason behind the increase is unclear, but we do know how…

Eye Care

Accuracy Gap In EHRs For Eye Care Patients

When it comes to keeping track of prescribe medications between clinic visits; many eye care patients rely on print medication lists automatically generate from electronic health records (EHRs). An examination of the EHRs of a cohort of ophthalmology patients reveal that one-third had at least one discrepancy; between the medications discuss in the clinician’s notes…

Age-Related Macular Degeneration

Age-Related Vision Loss Stopped By New Laser Therapy

About 200 million people are with age-related macular degeneration (AMD), and in approximately five of these cases; the disease progresses to an advance stage, leading to visual loss in the world. Advance AMD is divide into wet and dry forms. While wet AMD can be treat with medical injections; approximately four fifths of advance AMD…

Colour-Blindness Is Not Cured By O2Amp ‘Oxy-Iso’ Glasses

In their new study, the researchers find that the O2Amp “Oxy-Iso” glasses, market by the US company VINO Optics, neither improve the colour vision of people with colour-blindness nor correct their colour-blindness. The below study is part of a wider project being conduct at the Department of Optics of the University of Granada, Spain; to…

Macular Degeneration

Implanted Drug ‘Reservoir’ Reduces Injections For Macular Degeneration

In a clinical trial of 220 people with “wet” age-related macular degeneration, Johns Hopkins Medicine researchers, collaborators from many sites across the country, and Genentech in South San Francisco have added to evidence that using a new implant technology continuously delivers medication into the eyes is safe and effective in helping maintain vision and reduces…